Dr. Chou discussing his poster at AACR

Both Dr. Jeffrey Chou and Dr. Yaguang Xi presented research posters at the American Association for Cancer Research annual meeting in Washington this week.

Dr. Chou is the 2009 Lisa Dubow Research Fellow, and Dr. Xi received the award in 2008.

Dr. Xi’s research found a micro-RNA (miRNA) that made colorectal cancer cells more sensitive to 5-FU and also predicted which cells, and potentially which patients, response best to treatment with 5-FU.

Dr. Chou studied whether treating colorectal cancer cells with decitabine (DAC) could produce cancer-testis antigen in the cells and make them sensitive to immunotherapy. Read the rest of this entry »

C3 Board Chair Nancy Roach and C3 staffer Kate Murphy and were part of the Scientist-Survivor Program at the American Association for Cancer Research 101st Annual Meeting in Washington this week.

Nancy was a mentor for a group of patient advocates who were attending AACR .  For Kate this was a third AACR Annual Meeting.  She presented a poster about C3 and its work.

This year’s meeting theme Conquering Cancer Through Discovery Research led to more than 700 presentations and 6,500 posters presenting key basic and translational research. Read the rest of this entry »

Rona Yaeger MD

Rona Yaeger, MD is the 2010 Lisa Dubow Research Fellow, receiving the 2010 American Association for Cancer Research – Colorectal Cancer Coalition Fellows Grant.

The Award will be made tonight at a special dinner in honor of AACR Fellows Fund grantees.

Dr. Yaeger is from Memorial Sloan-Kettering Cancer Center in New York.  Her grant research will focus on inhibiting the AKT pathway in colorectal cancer cells. Read the rest of this entry »

C3 will represent people touched by colorectal cancer with the Stand Up to Cancer (SU2C) initiative by serving on the SU2C Advocacy Advisory Council. “Our role as advocates is to help shape the direction of the exciting research that will be funded by SU2C,” said Nancy Roach, C3 Board of Directors.

SU2C is a national effort to raise substantial monies for ground-breaking translational cancer research that will accelerate advances in patient care as well as in cancer prevention.   A program of the Entertainment Industry Foundation, SU2C was established by a group of media, entertainment, and philanthropic leaders whose lives have all been affected by cancer in significant ways. They have partnered with American Association for Cancer Research (AACR) to provide expert scientific oversight of this important initiative.

The centerpiece of this initiative will be a nationally televised fundraising event to air on September 5, 2008.  The networks have joined together in an unprecedented collaboration to donate one hour of simultaneous, commercial-free prime time for this program.

Read the rest of this entry »